- Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
-
Schmohl JU, Felices M, Oh F, Lenvik AJ, Lebeau AM, Panyam J, Miller JS, Vallera DA
- KMID: 2394832
- Cancer Res Treat.
- 2017 Oct;49(4):1140-1152.
- doi: 10.4143/crt.2016.491
PURPOSE: The selective elimination of cancer stem cells (CSCs) in tumor patients is a crucial goal because CSCs cause drug refractory relapse. To improve the current conventional bispecific immune-engager platform,... -
- CITED
-
- Close
- SHARE
-
- Close
